
Computational Fluid Dynamics, CFD
Iconovo has invested in the Autodesk Simulation CFD software. Iconovo CEO Dr Orest Lastow was previously head of the AstraZeneca CFD group and has long…

New lab facilities
Iconovo has moved into new lab facilities. The new facilities will allow us to perform verification and performance testing of the devices in development.…

Published paper in Journal of Aerosol Medicine and Pulmonary Drug Delivery
Iconovo CEO Dr Orest Lastow has published a paper in Journal of Aerosol Medicine and Pulmonary Drug Delivery. The paper is titled “Orally Inhaled Drug…

Great interest at DDL
Iconovo was a silver sponsor at DDL 25 in Edinburg, DDL Conference. DDL is the internationally most important inhalation conference held annually in Edinburg.…

Iconovo has raised 1 million USD for inhalation device development
Iconovo has raised 1 million USD in venture capital funding to develop inhalation devices. Lennart Holm has also increased his equity share in the company.…

Silver sponsor of MVIS
Iconovo is a silver sponsor of MVIS (Medicon Valley Inhalation Symposium) 15 October in Lund. We will exhibit our prototypes showing our recent development…


Iconovo represented at MEDTEC 2014
Orest Lastow was an invited speaker at MEDTEC Europe 2014 in Stuttgart. He talked about the use of quality by design, QbD, in the development of inhalation…
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se
CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se